Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02092038 : Preoperative Chemoradiation for Glioblastoma
PhasePhase 1
AgesMin: 18 Years Max: 80 Years
Eligibility
Inclusion Criteria:

- MRI lesions of the brain that have a high probability of being glioblastoma in a
potentially resectable location in the brain (the primary study population)

- WHO performance status 0-2 (to allow comparison to historical controls)

- Adequate hematological parameters: (for safety because of neutropenia from the
temozolomide)

- Consent can be obtained from the patient, and if the patient cannot give consent then
from the medical power of attorney and if one is not assigned, then the nearest
relative (required to obtain consent)

- Able to have MRI scans (secondary endpoint is MRI scan characteristics)

- Willing to have radiation treatment at a participating center (homogeneity of
treatment parameters)

- Ages 18-80

Exclusion Criteria:

- Unresectable tumor

- Absolute neutrophil count (ANC) less than 1,200/?L

- Hemoglobin less than 9.0g/dL

- Platelet count less than 100,000/?L
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT02092038      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740